The DOI matches its Crossref record; 266 of the 266 references it cites were found in a registry or an index.
The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–266 of 266
Rowlett, J. K. (2000) · Psychopharmacology · doi:10.1007/s002130000610 · Cited by 74
Parsons, L. H., Caine, S. B., Sokoloff, P., Schwartz, J., Koob, G. F., & Weiss, F. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67031078.x · Cited by 72
Selective D3 receptor agonist effects of (+)-PD 128907 on dialysate dopamine at low doses
Zapata, A. G., Witkin, J. M., & Shippenberg, T. S. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00069-7 · Cited by 72
Schwarz, A. J., Gozzi, A., Reese, T., Bertani, S., Crestan, V., Hagan, J. J., Heidbreder, C. A., & Bifone, A. (2004) · Synapse · doi:10.1002/syn.20055 · Cited by 72
Self-citationThe dopamine D3/D2 receptor agonist 7-OH-DPAT induces cognitive impairment in the marmoset
Smith, A. G., Neill, J. C., & Costall, B. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00230-5 · Cited by 71
G Bancroft, B. S. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00162-0 · Cited by 69
Hayes, R. J., Vorel, S. R., Spector, J. A., Liu, X., & Gardner, E. L. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1328-3 · Cited by 68
Self-citation7-OH-DPAT and PD 128907 Selectively Activate the D3 Dopamine Receptor in a Novel Environment
Pritchard, L. M., Logue, A. D., Hayes, S., Welge, J. A., Xu, M., Zhang, J., Berger, S. P., & Richtand, N. M. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300018 · Cited by 67
Wood, M. D., Boyfield, I., Nash, D. J., Jewitt, F., Avenell, K. Y., & Riley, G. J. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00732-9 · Cited by 65
Narita, M., Mizuo, K., Mizoguchi, H., Sakata, M., Narita, M., Tseng, L. F., & Suzuki, T. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-03-01006.2003 · Cited by 64
Newman, A. H., Cao, J., Bennett, C. J., Robarge, M. J., Freeman, R. A., & Luedtke, R. R. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00389-5 · Cited by 62
Austin, N. E., Baldwin, S. J., Cutler, L., Deeks, N. J., Kelly, P. J., Nash, M., Shardlow, C. E., Stemp, G., Thewlis, K. M., Ayrton, A. D., et al. (2001) · Xenobiotica · doi:10.1080/00498250110056531 · Cited by 62
Chaperon, F., Tricklebank, M. D., Unger, L., et al. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00113-8 · Cited by 61
Gyertyán, I., & Gál, K. (2003) · Neuroreport · doi:10.1097/00001756-200301200-00018 · Cited by 58
Sinnott, R. S., Mach, R. H., & Nader, M. A. (1999) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00162-8 · Cited by 57
Beardsley, P. M., Sokoloff, P., Balster, R. L., & Schwartz, J. C. (2001) · Behavioural Pharmacology · doi:10.1097/00008877-200102000-00001 · Cited by 56
Clifford, J. J., & Waddington, J. L. (1998) · Psychopharmacology · doi:10.1007/s002130050567 · Cited by 55
Ledford, C. C., Fuchs, R. A., & See, R. E. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300249 · Cited by 55
Antagonism of behavioral effects of cocaine by selective dopamine receptor blockers
Spealman, R. D. (1990) · Psychopharmacology · doi:10.1007/bf02253732 · Cited by 55
GABAergic blockade of cocaine-associated cue-induced increases in nucleus accumbens dopamine
Gerasimov, M. R., Schiffer, W. K., Gardner, E. L., Marsteller, D. A., Lennon, I. C., Taylor, S. J., Brodie, J. D., Ashby, C. R., & Dewey, S. L. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00800-7 · Cited by 54
Self-citationGarcia-Ladona, F. J., & Cox, B. F. (2003) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2003.tb00246.x · Cited by 53
Coldwell, M. C., Boyfield, I., Brown, A. M., Stemp, G., & Middlemiss, D. N. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702657 · Cited by 52
Chiang, Y., Chen, P., & Chen, J. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02522-8 · Cited by 52
Lamas, X., Negus, S. S., Mello, N. K., & Nader, M. A. (1996) · Psychopharmacology · doi:10.1007/bf02247435 · Cited by 52
Kurashima, M., Yamada, K., Nagashima, M., Shirakawa, K., & Furukawa, T. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)00103-4 · Cited by 51
Manzanedo, C., Aguilar, M. A., & Miñarro, J. (1999) · Psychopharmacology · doi:10.1007/s002130050922 · Cited by 50
Booze, R. M., & Wallace, D. R. (1995) · Synapse · doi:10.1002/syn.890190102 · Cited by 50
Gál, K., & Gyertyán, I. (2003) · Brain Research Bulletin · doi:10.1016/s0361-9230(03)00217-x · Cited by 50
A novel series of arylpiperazines with high affinity and selectivity for the dopamine D3 receptor
Murray, P. J., Harrison, L. A., Johnson, M. R., Robertson, G. M., Scopes, D. I. C., Bull, D., Graham, E. A., Hayes, A. G., Kilpatrick, G. J., den Daas, I., et al. (1995) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(95)00011-h · Cited by 49
Alderson, H. L., Robbins, T. W., & Everitt, B. J. (2000) · Psychopharmacology · doi:10.1007/s002130000527 · Cited by 47
Bristow, L. J., Cook, G. P., Patel, S. S., Curtis, N. R., Mawer, I. M., & Kulagowski, J. J. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00066-5 · Cited by 45
In Vivo Occupancy of D2 Dopamine Receptors by Nafadotride
Levant, B., & Vansell, N. R. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00024-9 · Cited by 41
Levant, B., & Souza, E. B. D. (1993) · Synapse · doi:10.1002/syn.890140112 · Cited by 41
Dopamine D3 receptor knockout mice and the motivational effects of ethanol
Boyce‐Rustay, J. M., & Risinger, F. O. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00091-1 · Cited by 40
Richtand, N. M., Logue, A. D., Welge, J. A., Perdiue, J., Tubbs, L. J., Spitzer, R. H., Sethuraman, G., & Geracioti, T. D. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02247-2 · Cited by 38
Respective roles of dopamine D2 and D3 receptors in food-seeking behaviour in rats
Duarte, C., Biała, G., Bihan, C. L., Hamon, M., & Thiébot, M.-H. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1310-0 · Cited by 37
Role of dopamine D3 receptors in the addictive properties of ethanol
Heidbreder, C. A., Andreoli, M., Marcon, C., Thanos, P. K., Ashby, C. R., & Gardner, E. L. (2004) · Drugs of today · doi:10.1358/dot.2004.40.4.820081 · Cited by 36
Self-citationCarr, K. D., Yamamoto, N., Omura, M., de Vaca, S. C., & Krahne, L. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1132-0 · Cited by 33
Khroyan, T. V., Fuchs, R. A., Beck, A. M., Groff, R. S., & Neisewander, J. L. (1999) · Psychopharmacology · doi:10.1007/s002130050903 · Cited by 33
Ukai, M., Tanaka, T., & Kameyama, T. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00075-7 · Cited by 32
Khroyan, T. V., Fuchs, R. A., Baker, D. L., & Neisewander, J. L. (1997) · Behavioural Pharmacology · doi:10.1097/00008877-199702000-00007 · Cited by 32
Relative affinities of dopaminergic drugs at dopamine D2 and D3 receptors
Levant, B., Grigoriadis, D. E., & Souza, E. B. D. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00160-m · Cited by 32
Enhancement of ethanol reward by dopamine D3 receptor blockade
Boyce, J. M., & Risinger, F. O. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02801-8 · Cited by 31
Intensification of the development of ethanol dependence in mice lacking dopamine D3 receptor
Narita, M., Soma, M., Tamaki, H., et al. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00235-5 · Cited by 31
Effects of intra-amygdala R (+) 7-OH-DPAT on intra-accumbens d -amphetamine-associated learning
Hitchcott, P. K., & Phillips, G. D. (1998) · Psychopharmacology · doi:10.1007/s002130050771 · Cited by 30
Rodríguez‐Arias, M., Felip, C. M., Broseta, I., & Miñarro, J. (1999) · Psychopharmacology · doi:10.1007/s002130050981 · Cited by 30
Smith, A. D., Smith, D. L., Zigmond, M. J., Amalric, M., & Koob, G. F. (2000) · Psychopharmacology · doi:10.1007/s002130050063 · Cited by 28
A dopamine D3 receptor partial agonist blocks the expression of conditioned activity
Aujla, H., Sokoloff, P., & Beninger, R. J. (2002) · Neuroreport · doi:10.1097/00001756-200201210-00039 · Cited by 28
Gendreau, P. L., Petitto, J. M., Schnauss, R., Frantz, K. J., Hartesveldt, C. V., Gariépy, J., & Lewis, M. H. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01324-1 · Cited by 24
Phillips, G. D., Harmer, C. J., & Hitchcott, P. K. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00034-7 · Cited by 23
Dopamine D3 receptor antagonist effects on the motivational effects of ethanol
Boyce, J. M., & Risinger, F. O. (2002) · Alcohol · doi:10.1016/s0741-8329(02)00237-9 · Cited by 23
Clark, D. T., Exner, M., Furmidge, L. J., Svensson, K. A., & Sonesson, C. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)00747-u · Cited by 22
Dickinson, S. D., Lee, E. L., Rindal, K. E., et al. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1270-4 · Cited by 21
Cussac, D., Newman‐Tancredi, A., Sezgin, L., & Millan, M. J. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00149-7 · Cited by 21
The D3 Dopamine Receptor and Substance Dependence
Richtand, N. M., Goldsmith, R. J., Nolan, J. E. B., & Berger, S. P. (2001) · Journal of Addictive Diseases · doi:10.1300/j069v20n03_03 · Cited by 20
Gehlert, D. R. (1993) · Synapse · doi:10.1002/syn.890140203 · Cited by 20
Differential effects of 7-OH-DPAT on amphetamine-induced stereotypy and conditioned place preference
Khroyan, T. V., Baker, D. L., Fuchs, R. A., Manders, N., & Neisewander, J. L. (1998) · Psychopharmacology · doi:10.1007/s002130050724 · Cited by 19
Dekeyne, A., Rivet, J., Gobert, A., & Millan, M. J. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00022-3 · Cited by 16
Effects of intra-amygdala R (+) 7-OH-DPAT on intra-accumbens d -amphetamine-associated learning
Hitchcott, P. K., & Phillips, G. D. (1998) · Psychopharmacology · doi:10.1007/s002130050772 · Cited by 16
Recent Advances in the Development of Dopamine D3 Receptor Agonists and Antagonists
Crider, A. M., & Scheideler, M. A. (2001) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557013407287 · Cited by 14
Mattingly, B. A., Caudill, A. K., & Abel, M. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00471-8 · Cited by 12
Pharmacological actions of a novel and selective dopamine D3 receptor antagonist, KCH-1110
Park, W. (2003) · Pharmacological Research · doi:10.1016/s1043-6618(03)00242-1 · Cited by 12
Isolation rearing-induced facilitation of Pavlovian learning
Phillips, G. D., Harmer, C. J., & Hitchcott, P. K. (2002) · Physiology & Behavior · doi:10.1016/s0031-9384(02)00802-8 · Cited by 11
Robinet, P. M., & Bardo, M. T. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00581-0 · Cited by 8
Nafadotride administration increases D1 and D1/D2 dopamine receptor mediated behaviors
DallʼOlio, R., GAGGI, R., Voltattorni, M., Tanda, O., & Gandolfi, O. (2002) · Behavioural Pharmacology · doi:10.1097/00008877-200212000-00004 · Cited by 6
Koch, S., Piercey, M. F., Galloway, M. P., & Svensson, K. A. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00852-7 · Cited by 5
Cited by
Addiction and Brain Reward and Antireward Pathways
Gardner, E. L. (2011) · Advances in Psychosomatic Medicine · doi:10.1159/000324065 · Cited by 417
Self-citationGoodman, A. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.030 · Cited by 413
Targeting the dopamine D2receptor in schizophrenia
Seeman, P. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.4.515 · Cited by 302
Heidbreder, C. A., & Newman, A. H. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05149.x · Cited by 273
Self-citationDevelopment of pharmacotherapies for drug addiction: a Rosetta stone approach
Koob, G. F., Kenneth Lloyd, G., & Mason, B. J. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2828 · Cited by 154
Metadata
- Authors
- Heidbreder, C. A., Gardner, E. L., Xi, Z.-X., Thanos, P. K., Mugnaini, M., Hagan, J. J., & Ashby, C. R.
- Venue
- Brain Research Reviews
- Publisher
- Elsevier BV
- Published
- 2005-07
- Volume
- 49
- Issue
- 1
- Pages
- 77-105
- ISSN
- 0165-0173 (ISSN-L)
- OpenAlex
- W2169584475
- Cited by
- 322
- References
- 266
- FWCI
- 8.83
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.